These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 17036956

  • 21. Ask the doctor. I read that angiotensin-receptor blockers cause cancer. I take one (Diovan) for my blood pressure. Should I stop?
    Lee T.
    Harv Heart Lett; 2010 Dec; 21(4):8. PubMed ID: 21218537
    [No Abstract] [Full Text] [Related]

  • 22. [Fetal toxicity of angiotensin-II-receptor inhibitors. Case report].
    Roger N, Popovic I, Madelenat P, Mahieu-Caputo D.
    Gynecol Obstet Fertil; 2007 Jun; 35(6):556-60. PubMed ID: 17544313
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [The taboo topic of sexual activity in hypertensive patients. Pioneer study from Pavia proves: potency is not impaired].
    MMW Fortschr Med; 2001 Jun 07; 143(23):48-9. PubMed ID: 11460426
    [No Abstract] [Full Text] [Related]

  • 26. Valsartan, captopril, or both in myocardial infarction.
    Moshenyat R, Kupfer Y, Tessler S.
    N Engl J Med; 2004 Feb 26; 350(9):943-5; author reply 943-5. PubMed ID: 14988935
    [No Abstract] [Full Text] [Related]

  • 27. Valsartan, captopril, or both in myocardial infarction.
    Jorde UP.
    N Engl J Med; 2004 Feb 26; 350(9):943-5; author reply 943-5. PubMed ID: 14988936
    [No Abstract] [Full Text] [Related]

  • 28. [Preventing end-organ damage in hypertension. What is the significance of the VALUE Study for general practice?].
    Zidek W.
    MMW Fortschr Med; 2004 Jul 08; 146(27-28):41. PubMed ID: 15526662
    [No Abstract] [Full Text] [Related]

  • 29. Now or never: optimal antihypertensive therapy in the elderly.
    Prisant LM.
    Prev Cardiol; 2008 Jul 08; 11(4):201-9. PubMed ID: 19476572
    [Abstract] [Full Text] [Related]

  • 30. [AT1 receptor antagonists in treatment of hypertension].
    Franz IW.
    Fortschr Med; 1997 Jul 10; 115(19):38-40. PubMed ID: 9333581
    [No Abstract] [Full Text] [Related]

  • 31. Lithium intoxication after valsartan treatment.
    Su YP, Chang CJ, Hwang TJ.
    Psychiatry Clin Neurosci; 2007 Apr 10; 61(2):204. PubMed ID: 17362443
    [No Abstract] [Full Text] [Related]

  • 32. [New options against undertreatment].
    Pfeffer M.
    MMW Fortschr Med; 2003 Dec 04; 145(49):18. PubMed ID: 14963987
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr 04; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 35. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A.
    Curr Med Res Opin; 2008 Aug 04; 24(8):2303-11. PubMed ID: 18593517
    [Abstract] [Full Text] [Related]

  • 36. [Kidney protection leads to heart protection, too].
    MMW Fortschr Med; 2006 Aug 17; 148(33-34):57. PubMed ID: 16981393
    [No Abstract] [Full Text] [Related]

  • 37. [Acute renal failure and hypertension].
    Bellido D, Sánchez de la Nieta MD, Vozmediano C, Oteros R, Zarca MA, Nieto J, Rivera F.
    Nefrologia; 2005 Aug 17; 25(5):563-7. PubMed ID: 16392308
    [Abstract] [Full Text] [Related]

  • 38. [Risk oriented therapy of hypertension. Lowering blood pressure and risk].
    MMW Fortschr Med; 2007 Nov 15; 149(46):53. PubMed ID: 18069196
    [No Abstract] [Full Text] [Related]

  • 39. Vildagliptin, a novel dipeptidyl peptidase IV inhibitor, has no pharmacokinetic interactions with the antihypertensive agents amlodipine, valsartan, and ramipril in healthy subjects.
    He YL, Ligueros-Saylan M, Sunkara G, Sabo R, Zhao C, Wang Y, Campestrini J, Pommier F, Dole K, Marion A, Dole WP, Howard D.
    J Clin Pharmacol; 2008 Jan 15; 48(1):85-95. PubMed ID: 17986525
    [Abstract] [Full Text] [Related]

  • 40. [High dose sartan plus diuretic. More power in hypertension and its sequelae].
    MMW Fortschr Med; 2003 Mar 13; 145(11):59. PubMed ID: 12688201
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.